Millions of patients with chronic diseases require regular blood tests to adjust their medication dosage - a process that previously required time-consuming visits to hospitals or laboratories. Heidelberg-based start-up QuantiLight has developed an innovative solution that fundamentally changes this process: a portable blood testing platform that allows patients to monitor their medication levels from the comfort of their own home..

数百万慢性病患者需要定期进行血液检测来调整药物剂量——这一过程以往需要耗时的医院或实验室访问。总部位于海德堡的初创公司QuantiLight开发了一种创新解决方案，从根本上改变了这一过程：一个便携式血液检测平台，让患者能够在家中舒适地监测自己的药物水平。

Innovative technology with easy handling

创新技术，操作简便

QuantiLight's core product is based on a patented sensor technology that can quantify biomarkers and drug concentrations in complex matrices with impressive precision. These bioluminescent sensors emit light that changes color depending on the concentration of the biomarker. Even at very low analyte concentrations in the nanomolar range, they can be easily detected with simple equipment such as a digital camera..

QuantiLight的核心产品基于一种获得专利的传感器技术，该技术可以以令人印象深刻的精确度量化复杂基质中的生物标志物和药物浓度。这些生物发光传感器发出的光会根据生物标志物的浓度改变颜色。即使在纳摩尔范围内的极低分析物浓度下，也可以使用数码相机等简单设备轻松检测到。

The system consists of three main components: a test cartridge, a handheld reader and a mobile app. The test only requires a drop of blood (5 μl) from a finger prick, which is applied to the test cartridge. The handheld reader analyzes the blood sample using proprietary technology and sends the results to the mobile app via Bluetooth.

该系统由三个主要组件组成：测试盒、手持读取器和移动应用程序。测试只需从手指采血一滴（5微升），将其应用于测试盒。手持读取器使用专有技术分析血液样本，并通过蓝牙将结果发送到移动应用程序。

Within just 15 minutes, patients receive the result of their current medication concentration and can make adjustments in consultation with their doctor if necessary..

仅需 15 分钟，患者便可获得其当前药物浓度的结果，并在必要时与医生协商进行调整。

From the Max Planck Institute to a promising start-up

从马克斯·普朗克研究所到充满希望的初创公司

QuantiLight has its roots in the Department of Chemical Biology at the Max Planck Institute for Medical Research. The founding team combines in-depth technological understanding with practical implementation experience to bring innovations to where they matter most - to the patients.

QuantiLight 源自马克斯普朗克医学研究所的化学生物学系。创始团队将深厚的技术理解与实际实施经验相结合，将创新带给最需要它们的人——患者。

The company is headed by CEO Corentin Gondrand, who has a doctorate in chemical biology. Estelle Bonedeau with a PhD in Molecular Biology serves as CTO, while Erin Federman with a Master's degree in Business Administration completes the management team as CCO. Prof. Kai Johnsson, Head of the Department of Chemical Biology at the Max Planck Institute for Medical Research, supports the young company with his expertise as an advisor..

公司由拥有化学生物学博士学位的首席执行官科伦丁·贡德兰领导，埃斯特尔·博内多担任首席技术官，她拥有分子生物学博士学位，而拥有工商管理硕士学位的艾琳·费德曼作为首席商务官完善了管理团队。马克斯·普朗克医学研究所化学生物系主任凯·约翰森教授以顾问身份为这家年轻公司提供专业支持。

Enormous market potential and benefits for the healthcare system

巨大的市场潜力和对医疗保健系统的益处

Therapeutic drug monitoring (TDM), for which QuantiLight has designed its solution, affects around 40 million patients worldwide. According to the company, 66% of these tests could be carried out from home. The benefits are obvious: patients save an average of 104 km of travel per test and receive their results within 15 minutes instead of days or weeks.

治疗药物监测 (TDM) 是 QuantiLight 设计其解决方案的领域，全球约有 4000 万名患者受到影响。据该公司称，其中 66% 的检测可以在家中进行。好处显而易见：患者每次检测平均可节省 104 公里的行程，并在 15 分钟内获得结果，而不是等待数天或数周。

For healthcare systems, the technology offers potential savings of up to 64%..

对于医疗系统，这项技术可提供高达64%的潜在节省。

The company is currently in an active development phase and is looking for contacts with healthcare professionals, potential partners and investors to take the next steps towards market launch. With its user-friendly approach and clear added value for all stakeholders - patients, physicians, laboratories and healthcare systems - QuantiLight could permanently change the way medication monitoring is carried out..

该公司目前正处于积极开发阶段，正在寻找与医疗专业人士、潜在合作伙伴和投资者的联系，以采取下一步措施走向市场推出。通过其用户友好的方法和为所有利益相关者（患者、医生、实验室和医疗系统）带来的明确附加价值，QuantiLight可能会永久改变药物监测的方式。

Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of current news. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar.

注意：本文已通过计算机系统翻译，未经人工干预。LUMITOS 提供这些自动翻译，以呈现更广泛的当前新闻。由于本文是通过自动翻译翻译的，因此可能包含词汇、句法或语法方面的错误。

The original article in German can be found .

德语原文可以找到。

here

这里

.

。

https://www.bionity.com/en/news/1186124/heidelberg-start-up-develops-system-for-precise-drug-monitoring-with-just-one-drop-of-blood.html

https://www.bionity.com/zh/news/1186124/海德堡初创公司开发出仅需一滴血即可精确监测药物的系统.html

Most read news

最受关注的新闻

1

1

What drives our cravings for food and drink?

是什么驱动了我们对食物和饮料的渴望？

2

2

Researchers bring prehistoric algae back to life

研究人员让史前藻类重获新生

3

3

Sensors against superbugs

传感器对抗超级细菌

4

4

Research breakthrough: Lab-grown teeth might become an alternative to fillings

研究突破：实验室培养的牙齿可能成为补牙的替代品

5

5

High blood pressure? Eat more bananas

高血压？多吃香蕉

Organizations

组织

QuantiLight

光量